2021 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2021 ASCO Highlights on Leukemias: Ponatinib in CML, Blinatumomab + Ponatinib in Ph+ ALL, KTE-X19 in R/R B-cell ALL, Acalabrutinib vs. Ibrutinib in CLL, Enasidenib in IDH2-Mutated MDS
By
2021 ASCO Virtual Direct™ Highlights
FEATURING
Tapan Kadia
By
2021 ASCO Virtual Direct™ Highlights
FEATURING
Tapan Kadia
0 views
August 19, 2021
Comments 0
Login to view comments.
Click here to Login
Jacksonville